中草药(英文版)(Chinese Herbal Medicines) 知网万方目次维普目次
- 科核
- 主管单位:
天津药物研究院
- 主办单位:
天津药物研究院;中国医学科学院药用植物研究所
- 国际刊号:
1674-6384
- 国内刊号:
12-1410/R
- 学科分类:
- 字数:
4000-30000
- 有无基金:
/有基金 100.0%
- 周期:
CN外文-季刊
- 特殊属性:
第一批认定学术期刊
- 电话:
022-23006901(202401期);010-57833035(官网电话)
- 邮箱:
见投稿指南处
- 复合因子:
1.053
- 综合因子:
0.655
- 收录:
知网,万方目次,维普目次
- 级别:
科核
期刊简介
《中草药》期刊已被查看: 次
更新频次
单位占比
一作占比
/有基金-100.0%投稿指南
1、投稿方式:在线投稿。
2、刊内网址:(202401期)
http://www.tiprpress.com
http://www.sciencedirect.com/journal/chinese-herbal-medicines
http://www.tiprpress.com/chmen/ch/index.aspx
http://www.elsevier.com/locate/chmed
https://mc03.manuscriptcentral.com/chm(投稿系统)
3、出刊日期:季刊,逢季首月18日出版。
2024年4月17日星期三
《中草药(英文版)》作者须知Instruction for Authors
【官网信息】
Chinese Herbal Medicines (CHM) is an official international journal sponsored by Tianjin Institute of Pharmaceutical Research and Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences. The purpose of CHM is to provide a forum for the studies on Chinese herbal medicines, phytomedicines, and natural products as well. The journal will accept the following contributions: letters, original articles, review papers, short communications, book reviews, conference announcements, information, etc. The journal involves the studies on active ingredients and complex formulations of herbal medicines in medicinal resource, phytochemistry, pharmacology, toxicology, pharmacokinetics, and therapeutic function by experiment and clinical trials. It is the interest of this journal to introduce the latest development in pharmaceutical sciences to readers.
The journal is included in the following databases: ESCI, PubMed Central, Scopus, DOAJ, CAB ABSTRACTS, CAS, EMBASE, IC, UPD, Global Health, etc. Since 2013, CHM has been selected as one of the Chinese Core Periodicals of Science and Technology for nine consecutive years. In 2019, CHM was successfully selected by China Association for Science and Technology for the China Science and Technology Journal Excellence Action Plan. The journal has been awarded the distinction of Excellent International Impact Academic Journals of China in 2016, 2019, 2020, 2021 and 2022.
1. Submission of manuscripts
Authors could submit their manuscripts through online submission http://mc03.manuscriptcentral.com/chm. The following should be complied with: size of character 12 point, double-spaced, consecutive numbering of the lines and pages. The text should be in Word document for Windows.
2. Structure of manuscripts
2.1 Title
Please provide a title that is concise, informative, and relevant, ideally it should contain no more than 30 words.
2.2 Authors and affiliation
Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Capitalize the first letter in the surname(s) and spell out the given name(s) in full-name form. The corresponding author should be indicated by an asterisk (*) to the right of the name and the e-mail address given in the footnote. The affiliation of each author should be provided, including complete address information (city, zip code, and country). Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address.
Any change in authorship must be approved in writing by all authors. Authors who have contributed equally should be marked with a superscript symbol (1). The following statement added in the footnote: “These authors contributed equally to this work”. The equal roles of authors should also be adequately disclosed in the authors’ contributions statement.
2.3 Abstract
The paper should contain an abstract with 200–300 words in English. The abstract should summarize the main points of the article. The structure form of the abstract should consist of Objective (purpose of the study), Methods (basic procedures), Results (final findings with main data), and Conclusion (potential possibility on the result).
……
更多详情:
https://www.tiprpress.com/chmen/site/menu/20100204181305001
《中草药》同类中国医学期刊
-
时珍国医国药
北核,CSCD扩,武A-,高T2
CN中文-月刊影响因子1.462
-
中华中医药杂志(原:中国医药学报)
北核,CSCD,科核,武A,高T1
CN中文-月刊影响因子2.346
-
中药材
北核,科核,武A-
CN中文-月刊影响因子1.748
-
中医杂志
北核,CSCD,科核,武A,高T1
CN中文-半月刊影响因子4.487
-
中华中医药学刊
北核,科核,武A,高T1
CN中文-月刊影响因子2.975
-
中国中医基础医学杂志
科核,CSCD扩,高T2,武B+
CN中文-月刊影响因子1.824
-
中成药
北核,CSCD,科核,武A,高T2
CN中文-月刊影响因子2.225
-
中国中西医结合杂志
北核,CSCD,科核,武A+,高T1
CN中文-月刊影响因子2.683
常见问题
-
中草药杂志社官网、联系方式是什么?
中草药杂志社官网:http://www.tiprpress.com/chmen/ch/index.aspx
投稿网址:https://mc03.manuscriptcentral.com/chm联系电话:022-23006901(202401期);010-57833035(官网电话)
投稿邮箱:见投稿指南处 -
中草药杂志是核心期刊么?
中草药是核心期刊,级别是:科核, 是:中国医学分类下的知网,万方目次,维普目次收录的期刊。
-
请问你们是中草药杂志社吗?
我们不是《中草药》杂志社。本站主要从事期刊信息展示与期刊推荐,不是任何杂志官网,直投稿件请联系杂志社。本站仅提供免费的学术指导、论文辅导、期刊投稿信息整理收集服务。
-
你们指导服务后可以保证文章被发表吗?
期刊发表的成功与否,主要取决于文章内容的质量。编辑老师会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。
-
晋级论文能否在报纸上发表?
在学术界,论文的发表往往被视为研究者职业发展的重要一环。晋级论文,即为了获得更高职称或学术地位而撰写的学术论文,通常需在专业期刊上发表。然而,许多人可能会问